Inhibition of PKA attenuates memory deficits induced by β-amyloid (1-42), and decreases oxidative stress and NF-κB transcription factors

Behavioural Brain Research

Volumn 226, Issue 1, 2012, Pages 301-308

  Eftekharzadeh, Bahareh ^a,b   Ramin, Mahmoudreza ^b   Khodagholi, Fariba ^b   Moradi, Shahla ^a   Tabrizian, Kaveh ^c   Sharif, Rojin ^a   Azami, Kian ^a   Beyer, Cordian ^d   Sharifzadeh, Mohammad ^a,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Amyloid ; H 89; Morris water maze; NF B transcription factor

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; SUPEROXIDE DISMUTASE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR MODIFICATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; GENE OVEREXPRESSION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; LATENT PERIOD; MALE; MICROINJECTION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TRAINING;

AMYLOID BETA-PEPTIDES; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLUTATHIONE; HIPPOCAMPUS; ISOQUINOLINES; MALE; MAZE LEARNING; MEMORY DISORDERS; MEMORY, SHORT-TERM; NF-KAPPA B; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; SULFONAMIDES;

EID: 80054835111     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.08.015     Document Type: Article

References (67)

1. Aliev G., Seyidova D., Neal M.L., Shi J., Lamb B.T., Siedlak S.L., et al. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann N Y Acad Sci 2002, 977:45-64.
2. Arun P., Brown M.S., Ehsanian R., Chen Z., Van Waes C. Nuclear NF-kappaB p65 phosphorylation at serine 276 by protein kinase A contributes to the malignant phenotype of head and neck cancer. Clin Cancer Res 2009, 15:5974-5984.
3. Awasthi A., Matsunaga Y., Yamada T. Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides. Exp Neurol 2005, 196:282-289.
4. Azami K., Etminani M., Tabrizian K., Salar F., Belaran M., Hosseini A., et al. The quantitative evaluation of cholinergic markers in spatial memory improvement induced by nicotine-bucladesine combination in rats. Eur J Pharmacol 2010, 636:102-107.
5. Bales K.R., Du Y., Dodel R.C., Yan G.M., Hamilton-Byrd E., Paul S.M. The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation. Brain Res Mol Brain Res 1998, 57:63-72.
6. Bethea J.R., Castro M., Keane R.W., Lee T.T., Dietrich W.D., Yezierski R.P. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci 1998, 18:3251-3260.
7. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
8. Braithwaite S.P., Schmid R.S., He D.N., Sung M-LA, Cho S., Resnick L., et al. Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease. Neurobiol Dis 2010, 39:311-317.
9. Brandeis R., Brandys Y., Yehuda S. The use of the Morris Water Maze in the study of memory and learning. Int J Neurosci 1989, 48:29-69.
10. Burrell B., Sahley C. Learning in simple systems. Curr Opin Neurobiol 2001, 11:757-764.
11. Castellani R., Smith M.A., Richey P.L., Perry G. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 1996, 737:195-200.
12. Cetin F., Dincer S. The effect of intrahippocampal beta amyloid (1-42) peptide injection on oxidant and antioxidant status in rat brain. Ann N Y Acad Sci 2007, 1100:510-517.
13. Coughlan C.M., Breen K.C. Factors influencing the processing and function of the amyloid beta precursor protein-a potential therapeutic target in Alzheimer's disease?. Pharmacol Ther 2000, 86:111-145.
14. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993, 262:689-695.
15. Dean O., Bush A.I., Berk M., Copolov D.L., van den Buuse M. Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice. Behav Brain Res 2009, 198:258-262.
16. Drain P., Folkers E., Quinn W.G. cAMP-dependent protein kinase and the disruption of learning in transgenic flies. Neuron 1991, 6:71-82.
17. Dvorak Z., Vrzal R., Maurel P., Ulrichova J. Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-kappaB in HeLa cells. Chem Biol Interact 2006, 159:117-128.
18. Eftekharzadeh B., Maghsoudi N., Khodagholi F. Stabilization of transcription factor Nrf2 by tBHQ prevents oxidative stress-induced amyloid beta formation in NT2N neurons. Biochimie 2010, 92:245-253.
19. Ellman G. Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82:70-77.
20. Estus S., Tucker H., van Rooyen C., Wright S., Brigham E., Wogulis M., et al. Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant apoptotic pattern of gene induction. J Neurosci 1997, 17:7736.
21. Flood D.G., Lin Y-G., Lang D.M., Trusko S.P., Hirsch J.D., Savage M.J., et al. A transgenic rat model of Alzheimer's disease with extracellular A[beta] deposition. Neurobiol Aging 2009, 30:1078-1090.
22. Gong B., Vitolo O.V., Trinchese F., Liu S., Shelanski M., Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 2004, 114:1624-1634.
23. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
24. Hui L., Hong Y., Jingjing Z. HGF suppresses high glucose-mediated oxidative stress in mesangial cells by activation of PKG and inhibition of PKA. Free Radic Biol Med 2010, 49:467-473.
25. Impey S., Obrietan K., Storm D. Making new connections: minireview role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 1999, 23:11-14.
26. Janowiak B.E., Hayward M.A., Peterson F.C., Volkman B.F., Griffith O.W. Gamma-glutamylcysteine synthetase-glutathione synthetase: domain structure and identification of residues important in substrate and glutathione binding. Biochemistry 2006, 45:10461-10473.
27. Jhoo J.H., Kim H.C., Nabeshima T., Yamada K., Shin E.J., Jhoo W.K., et al. Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. Behav Brain Res 2004, 155:185-196.
28. Kakkar P., Das B., Viswanathan P. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984, 21:130.
29. Kandel E., Schwartz J., Jessell ThM. Principles of neural science 2000, McGraw-Hill.
30. Kanninen K., Malm T.M., Jyrkkanen H.K., Goldsteins G., Keksa-Goldsteine V., Tanila H., et al. Nuclear factor erythroid 2-related factor 2 protects against beta amyloid. Mol Cell Neurosci 2008, 39:302-313.
31. Kim H.C., Yamada K., Nitta A., Olariu A., Tran M.H., Mizuno M., et al. Immunocytochemical evidence that amyloid beta (1-42) impairs endogenous antioxidant systems in vivo. Neuroscience 2003, 119:399-419.
32. Kim H.S., Lim J.Y., Sul D., Hwang B.Y., Won T.J., Hwang K.W., et al. Neuroprotective effects of the new diterpene, CBNU06 against beta-amyloid-induced toxicity through the inhibition of NF-kappaB signaling pathway in PC12 cells. Eur J Pharmacol 2009, 622:25-31.
33. Kimura Y., Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J 2004, 04.
34. Koriyama Y., Chiba K., Mohri T. Propentofylline protects beta-amyloid protein-induced apoptosis in cultured rat hippocampal neurons. Eur J Pharmacol 2003, 458:235-241.
35. Liou H.C., Baltimore D. Regulation of the NF-(B/rel transcription factor and I(B inhibitor system. Curr Opin Cell Biol 1993, 5:477-487.
36. Liu L., Orozco I.J., Planel E., Wen Y., Bretteville A., Krishnamurthy P., et al. A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. Neurobiol Dis 2008, 31:46-57.
37. Longpre F., Garneau P., Christen Y., Ramassamy C. Protection by EGb 761 against beta-amyloid-induced neurotoxicity: involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation. Free Radic Biol Med 2006, 41:1781-1794.
38. Maines M.D. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997, 37:517-554.
39. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
40. McNally S.J., Harrison E.M., Ross J.A., Garden O.J., Wigmore S.J. Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int J Mol Med 2007, 19:165-172.
41. Morris R.G., Garrud P., Rawlins J.N., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982, 297:681-683.
42. Nakayama K., Shimizu H., Mitomo K., Watanabe T., Okamoto S., Yamamoto K. A lymphoid cell-specific nuclear factor containing c-Rel-like proteins preferentially interacts with interleukin-6 kappa B-related motifs whose activities are repressed in lymphoid cells. Mol Cell Biol 1992, 12:1736-1746.
43. Nguyen P.V., Woo N.H. Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases. Prog Neurobiol 2003, 71:401-437.
44. Ogborne R.M., Rushworth S.A., Charalambos C.A., O'Connell M.A. Haem oxygenase-1: a target for dietary antioxidants. Biochem Soc Trans 2004, 32:1003-1005.
45. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1997, Academic Press, New York.
46. Ponka P. Cell biology of heme. Am J Med Sci 1999, 318:241-256.
47. Prapong T., Uemura E., Hsu W.H., Protein G. cAMP-dependent protein kinase mediate amyloid [beta]-peptide inhibition of neuronal glucose uptake. Exp Neurol 2001, 167:59-64.
48. Rong Y., Baudry M. Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures. J Neurochem 1996, 67:662-668.
49. Sakon S., Xue X., Takekawa M., Sasazuki T., Okazaki T., Kojima Y., et al. NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 2003, 22:3898-3909.
50. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med 1999, 5:554-559.
51. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001, 81:741-766.
52. Sharifzadeh M., Sharifzadeh K., Naghdi N., Ghahremani M.H., Roghani A. Posttraining intrahippocampal infusion of a protein kinase AII inhibitor impairs spatial memory retention in rats. J Neurosci Res 2005, 79:392-400.
53. Shen Y.X., Xu S.Y., Wei W., Wang X.L., Wang H., Sun X. Melatonin blocks rat hippocampal neuronal apoptosis induced by amyloid beta-peptide 25-35. J Pineal Res 2002, 32:163-167.
54. Simonian N., Coyle J. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 1996, 36:83-106.
55. Smith D.L., Pozueta J., Gong B., Arancio O., Shelanski M. Reversal of long-term dendritic spine alterations in Alzheimer disease models. Proc Natl Acad Sci USA 2009, 106:16877.
56. Su Y., Ryder J., Ni B. Inhibition of A[beta] production and APP maturation by a specific PKA inhibitor. FEBS Lett 2003, 546:407-410.
57. Sweatt J.D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 2001, 76:1-10.
58. Tenhunen R., Marver H.S., Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 1969, 244:6388-6394.
59. Terai K., Matsuo A., McGeer P.L. Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Res 1996, 735:159-168.
60. Ueda K., Yagami T., Kageyama H., Kawasaki K. Protein kinase inhibitor attenuates apoptotic cell death induced by amyloid beta protein in culture of the rat cerebral cortex. Neurosci Lett 1996, 203:175-178.
61. Urata Y., Yamamoto H., Goto S., Tsushima H., Akazawa S., Yamashita S., et al. Long exposure to high glucose concentration impairs the responsive expression of (-glutamylcysteine synthetase by interleukin-1β and tumor necrosis factor-α in mouse endothelial cells journal of biological. Chemistry 1996, 271:15146-15152.
62. Vitolo O.V., Sant'Angelo A., Costanzo V., Battaglia F., Arancio O., Shelanski M. Amyloid-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci USA 2002, 99:13217.
63. Wang Q.W., Rowan M.J., Anwyl R. Inhibition of LTP by beta-amyloid is prevented by activation of beta2 adrenoceptors and stimulation of the cAMP/PKA signalling pathway. Neurobiol Aging 2009, 30:1608-1613.
64. Wei Z., Song M., MacTavish D., Jhamandas J., Kar S. Role of calpain and caspase in [beta]-amyloid-induced cell death in rat primary septal cultured neurons. Neuropharmacology 2008, 54:721-733.
65. Xiong M., Zhang T., Zhang L., Lu S., Huang Y., Sun F. Caspase inhibition attenuates accumulation of [beta]-amyloid by reducing [beta]-secretase production and activity in rat brains after stroke. Neurobiol Dis 2008, 32:433-441.
66. Yan S.D., Chen X., Schmidt A.M., Brett J., Godman G., Zou Y.S., et al. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 1994, 91:7787-7791.
67. Zraika S., Hull R.L., Udayasankar J., Aston-Mourney K., Subramanian S.L., Kisilevsky R., et al. Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis. Diabetologia 2009, 52:626-635.